Prelude Capital Management, LLC Bristol Myers Squibb CO Transaction History

Prelude Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $1,484 - $877,666	11,422 Added 318.07%	15,013 $1.07 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $425,843 - $469,002	-5,864 Reduced 62.02%	3,591 $277,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $245,571 - $286,279	-4,579 Reduced 32.63%	9,455 $590,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $1.82 Million - $1.98 Million	-29,332 Reduced 67.64%	14,034 $938,000
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $1.16 Million - $1.31 Million	19,595 Added 82.43%	43,366 $2.75 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $268,944 - $298,026	4,683 Added 24.53%	23,771 $1.43 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $897,049 - $1.17 Million	18,229 Added 2122.12%	19,088 $1.23 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $553,003 - $623,745	-10,020 Reduced 92.1%	859 $53,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $289,183 - $360,434	-5,723 Reduced 34.47%	10,879 $602,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $50,452 - $58,081	-842 Reduced 4.83%	16,602 $1.05 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $272,187 - $296,754	-4,541 Reduced 20.65%	17,444 $1.07 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $1.21 Million - $1.4 Million	21,985	21,985 $1.4 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.